<DOC>
	<DOCNO>NCT00652886</DOCNO>
	<brief_summary>-To compare single dose bioavailability Kali BTG</brief_summary>
	<brief_title>Bioavailability Study Oxandrolone Tablets Under Fasting Conditions</brief_title>
	<detailed_description>-To compare bioavailability Oxandrolone 10mg tablet OXANDRIN 10mg tablet follow single -dose healthy , adult subject fast condition .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Oxandrolone</mesh_term>
	<criteria>Healthy subject least 18 year age , may male may female unable bear child . Each subject shall give general physical examination within 28days initiation study . At end study , subject exit evaluation consist interim history , global evaluation , clinical laboratory measurement . Each female subject give serum test part pregnancy study screen process . Clinical laboratory measurement include Hematology , Clinical Chemistry , Urine Analysis , HIV Screen , hepatitisB , C screen Drugs abuse Screen Subjects history alcoholism drug addiction ( past 2 year ) , serious gastrointestinal , renal hepatic cardiovascular disease , tuberculosis , epilepsy . asthma , diabetes , psychosis glaucoma eligible thsi study . Subjects history breast prostate cancer eligible participate study . Subjects history allergic response class drug test exclude study . Subjects find urine/saliva concentration test drug allow participate . Subjects take investigational drug within thirty day prior first dose study allow participate . Female subject able bear child allow participate . Female subject positive inconclusive result withdrawn study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Bioequivalence , Oxandrolone , fast</keyword>
</DOC>